BNP Paribas Financial Markets’s GoodRx Holdings GDRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.98K	Buy	3,053 +35	+1%	+$82	﹤0.01%	5299
2025 Q4	$8.18K	Sell	3,018 -167,927	-98%	-$551K	﹤0.01%	5195
2025 Q3	$723K	Sell	170,945 -51,741	-23%	-$227K	﹤0.01%	3358
2025 Q2	$1.11M	Buy	222,686 +52,289	+31%	+$227K	﹤0.01%	2846
2025 Q1	$751K	Buy	170,397 +131,112	+334%	+$615K	﹤0.01%	2961
2024 Q4	$183K	Buy	+39,285	New	+$216K	﹤0.01%	3916
2022 Q4	–	Sell	-164,004	Closed	-$766K	–	4257
2022 Q3	$766K	Buy	+164,004	New	+$1.03M	﹤0.01%	2682

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

BNP Paribas Financial Markets's GDRX Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its GoodRx Holdings (GDRX) stake by 1.2% in Q1 2026, buying an estimated $82 and bringing the position to 3,053 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #5299.

BNP Paribas Financial Markets first reported a position in GDRX in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.11M in Q2 2025. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

BNP Paribas Financial Markets held 3,053 shares of GoodRx Holdings worth $5.98K as of Q1 2026.
BNP Paribas Financial Markets bought 35 GoodRx Holdings shares in Q1 2026, an estimated $82.
GoodRx Holdings made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5299 holding.
BNP Paribas Financial Markets first reported a position in GoodRx Holdings in Q3 2022 and has held it in 7 quarters since.
BNP Paribas Financial Markets's GoodRx Holdings position peaked at $1.11M in Q2 2025.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.